Clinical Trial Update: Tirzepatide for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for tirzepatide (Mounjaro) in alcohol use disorder, with recruitment ongoing and exploration of obesity/overweight outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Obesity
• Overweight

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

Sponsor: University of Southern California | Conditions: Alcohol Use Disorder, Obesity and Overweight | Phase 2 | Status: RECRUITING